118 related articles for article (PubMed ID: 33325396)
1. Potential Sex-Specific Effects of Apolipoprotein E ɛ4 on Cognitive Decline in Early Parkinson's Disease.
Kim R; Park S; Yoo D; Ju Suh Y; Jun JS; Jeon B
J Parkinsons Dis; 2021; 11(2):497-505. PubMed ID: 33325396
[TBL] [Abstract][Full Text] [Related]
2. An increased rate of longitudinal cognitive decline is observed in Parkinson's disease patients with low CSF Aß42 and an APOE ε4 allele.
Shahid M; Kim J; Leaver K; Hendershott T; Zhu D; Cholerton B; Henderson VW; Tian L; Poston KL
Neurobiol Dis; 2019 Jul; 127():278-286. PubMed ID: 30826425
[TBL] [Abstract][Full Text] [Related]
3. Age-Related Association Between APOE ɛ4 and Cognitive Progression in de novo Parkinson's Disease.
Liu JY; Ma LZ; Wang J; Cui XJ; Sheng ZH; Fu Y; Li M; Ou YN; Yu JT; Tan L; Lian Y
J Alzheimers Dis; 2023; 91(3):1121-1132. PubMed ID: 36565124
[TBL] [Abstract][Full Text] [Related]
4. Association of Physical Activity and
Kim R; Park S; Yoo D; Jun JS; Jeon B
Neurology; 2021 May; 96(19):e2429-e2437. PubMed ID: 33790041
[TBL] [Abstract][Full Text] [Related]
5. Association of Vitamin E and Cognitive Decline in Older Adults with and without the APOEɛ4 Allele: A Biracial Population-Based Community Study.
Liu X; Finno CJ; Beck T; Dhana K; Tangney C; Desai P; Krueger K; Evans DA; Rajan KB
J Alzheimers Dis; 2023; 96(3):1129-1138. PubMed ID: 37955092
[TBL] [Abstract][Full Text] [Related]
6. Segmented Linear Mixed Model Analysis Reveals Association of the APOEɛ4 Allele with Faster Rate of Alzheimer's Disease Dementia Progression.
Chen XR; Shao Y; Sadowski MJ;
J Alzheimers Dis; 2021; 82(3):921-937. PubMed ID: 34120907
[TBL] [Abstract][Full Text] [Related]
7. Race, APOEɛ4, and Long-Term Cognitive Trajectories in a Biracial Population Sample.
Rajan KB; McAninch EA; Wilson RS; Weuve J; Barnes LL; Evans DA
J Alzheimers Dis; 2019; 72(1):45-53. PubMed ID: 31561363
[TBL] [Abstract][Full Text] [Related]
8. Cognitive Reserve, Brain Reserve, APOEɛ4, and Cognition in Individuals with Subjective Cognitive Decline in the SILCODE Study.
Yang K; Chen G; Sheng C; Xie Y; Li Y; Hu X; Sun Y; Han Y
J Alzheimers Dis; 2020; 76(1):249-260. PubMed ID: 32444543
[TBL] [Abstract][Full Text] [Related]
9. Effects of APOEɛ4 genotype on age-associated change in cognitive functions among Japanese middle-aged and older adults: A 20-year follow-up study.
Nishita Y; Sala G; Shinohara M; Tange C; Ando F; Shimokata H; Sato N; Otsuka R
Exp Gerontol; 2023 Jan; 171():112036. PubMed ID: 36435340
[TBL] [Abstract][Full Text] [Related]
10. A Network of Genetic Effects on Non-Demented Cognitive Aging: Alzheimer's Genetic Risk (CLU + CR1 + PICALM) Intensifies Cognitive Aging Genetic Risk (COMT + BDNF) Selectively for APOEɛ4 Carriers.
Sapkota S; Dixon RA
J Alzheimers Dis; 2018; 62(2):887-900. PubMed ID: 29480189
[TBL] [Abstract][Full Text] [Related]
11. APOE, MAPT, and COMT and Parkinson's Disease Susceptibility and Cognitive Symptom Progression.
Paul KC; Rausch R; Creek MM; Sinsheimer JS; Bronstein JM; Bordelon Y; Ritz B
J Parkinsons Dis; 2016 Apr; 6(2):349-59. PubMed ID: 27061069
[TBL] [Abstract][Full Text] [Related]
12. APOEɛ4 Gene Dose and Sex Effects on Alzheimer's Disease MRI Biomarkers in Older Adults with Mild Cognitive Impairment.
Hobel Z; Isenberg AL; Raghupathy D; Mack W; Pa J;
J Alzheimers Dis; 2019; 71(2):647-658. PubMed ID: 31424388
[TBL] [Abstract][Full Text] [Related]
13. Impact of the apolipoprotein E ε4 allele on early Parkinson's disease progression.
Kim R; Park S; Yoo D; Jun JS; Jeon B
Parkinsonism Relat Disord; 2021 Feb; 83():66-70. PubMed ID: 33484977
[TBL] [Abstract][Full Text] [Related]
14. APOE, thought disorder, and SPARE-AD predict cognitive decline in established Parkinson's disease.
Tropea TF; Xie SX; Rick J; Chahine LM; Dahodwala N; Doshi J; Davatzikos C; Shaw LM; Van Deerlin V; Trojanowski JQ; Weintraub D; Chen-Plotkin AS
Mov Disord; 2018 Feb; 33(2):289-297. PubMed ID: 29168904
[TBL] [Abstract][Full Text] [Related]
15. Association of Butyrylcholinesterase-K Allele and Apolipoprotein E ɛ4 Allele with Cognitive Decline in Dementia with Lewy Bodies and Alzheimer's Disease.
Vijayaraghavan S; Darreh-Shori T; Rongve A; Berge G; Sando SB; White LR; Auestad BH; Witoelar A; Andreassen OA; Ulstein ID; Aarsland D
J Alzheimers Dis; 2016; 50(2):567-76. PubMed ID: 26757188
[TBL] [Abstract][Full Text] [Related]
16. Interaction of Alzheimer's Disease-Associated Genetic Risk with Indicators of Socioeconomic Position on Mild Cognitive Impairment in the Heinz Nixdorf Recall Study.
Frank M; Hensel J; Baak L; Schramm S; Dragano N; Weimar C; Hoffmann P; Nöthen MM; Erbel R; Jöckel KH; Jokisch M; Schmidt B
J Alzheimers Dis; 2021; 82(4):1715-1725. PubMed ID: 34219719
[TBL] [Abstract][Full Text] [Related]
17. Impact of APOE and BDNF Val66Met Gene Polymorphisms on Cognitive Functions in Patients with Amnestic Mild Cognitive Impairment.
Cechova K; Andel R; Angelucci F; Chmatalova Z; Markova H; Laczó J; Vyhnalek M; Matoska V; Kaplan V; Nedelska Z; Ward DD; Hort J
J Alzheimers Dis; 2020; 73(1):247-257. PubMed ID: 31771052
[TBL] [Abstract][Full Text] [Related]
18. Smoking, APOE Genotype, and Cognitive Decline: The Rotterdam Study.
Wingbermühle R; Wen KX; Wolters FJ; Ikram MA; Bos D
J Alzheimers Dis; 2017; 57(4):1191-1195. PubMed ID: 28304310
[TBL] [Abstract][Full Text] [Related]
19. The role of APOE in cognitive trajectories and motor decline in Parkinson's disease.
Jo S; Kim SO; Park KW; Lee SH; Hwang YS; Chung SJ
Sci Rep; 2021 Apr; 11(1):7819. PubMed ID: 33837234
[TBL] [Abstract][Full Text] [Related]
20. Responsiveness to Change of the Montreal Cognitive Assessment, Mini-Mental State Examination, and SCOPA-Cog in Non-Demented Patients with Parkinson's Disease.
Faust-Socher A; Duff-Canning S; Grabovsky A; Armstrong MJ; Rothberg B; Eslinger PJ; Meaney CA; Schneider RB; Tang-Wai DF; Fox SH; Zadikoff C; Kennedy N; Chou KL; Persad C; Litvan I; Mast BT; Gerstenecker AT; Weintraub S; Reginold W; Marras C
Dement Geriatr Cogn Disord; 2019; 47(4-6):187-197. PubMed ID: 31315127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
